C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.67 AUD
-1.76%
Market Closed
Updated:
May 15, 2024
Cyclopharm Ltd
Gross Profit
|
Cyclopharm Ltd
Gross Profit Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Gross Profit
AU$17.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Gross Profit
AU$1.3m
|
CAGR 3-Years
192%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Gross Profit
AU$9.1m
|
CAGR 3-Years
24%
|
CAGR 5-Years
31%
|
CAGR 10-Years
16%
|
|
|
Cochlear Ltd
ASX:COH
|
Gross Profit
AU$1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Gross Profit
AU$2.5m
|
CAGR 3-Years
223%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Gross Profit?
Gross Profit
17.5m
AUD
17.5m
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Gross Profit amounts to 17.5m AUD.
What is Cyclopharm Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
8%
8%
Over the last year, the Gross Profit growth was 0%. The average annual Gross Profit growth rates for Cyclopharm Ltd have been 18% over the past three years , 11% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
